Analysis of clinical experience of children with toxic epidermal necropysis
https://doi.org/10.21508/1027-4065-2020-65-5-181-186
Abstract
Toxic epidermal necrolysis (TEN) is a severe drug allergy. The objective was to analyze the clinical experience of 17 children of different age with toxic epidermal necrolysis. The authors found that medications against infection diseases were the most common reason for the development of the disease. In some cases we observed the delayed diagnosis, therapy without consideration of causative agents, and wrong doses of corticosteroids. The majority of cases require combined use of corticosteroids and intravenous immunoglobulins, however bacterial complications are possible in some cases.
About the Authors
R. F. KhakimovaRussian Federation
O. V. Skorokhodkina
Russian Federation
G. M. Zaynetdinova
Russian Federation
Kazan
G. A. Shamsutdinova
Russian Federation
Kazan
G. R. Ryzhova
Russian Federation
Kazan
M. R. Khakimova
Russian Federation
D. A. Volkova
Russian Federation
References
1. Haitov R.M., Ilyina N.I. Allergology and Immunology: National Recommendations. Moscow: GEOTAR-Media, 2009; 656. (in Russ.)
2. Hsu D.Y., Brieva J., Silverberg N.B., PallerA.S., Silverberg J.I. Pediatric Stevens-Johnson syndrome and toxic epidermal necrolysis in the United States. J Am Acad Dermatol 2017; 76(5): 811-817. DOI: 10.1016/j.jaad.2016.12.024
3. Fakoya A.O.J., Omenyi P., Anthony P., Anthony F, Etti P, Otohinoyi D.A., Olunu E. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis; Extensive Review of Reports of Drug-Induced Etiologies, and Possible Therapeutic Modalities. Open Access Maced J Med Sci 2018; 6(4): 730—738. DOI: 10.3889/oamjms.2018.148
4. Ardern-Jones M.R., Friedmann P.S. Skin manifestations of drug allergy. Br J Clin Pharmacol 2011; 71(5): 672—683. DOI: 10.1111/j.1365-2125.2010.03703.x
5. Allergology and clinical immunology. Clinical recommendations. R.M. Khaitov, N.I. Ilyina (eds). Moscow: GEOTAR-Media, 2019; 352. (in Russ.)
6. Hoetzenecker W., Mehra T., Saulite I., GlatzM., Schmid-Gren-delmeier P., Guenova E. et al. Toxical epidermal necrolysis. F1000Res 2016; 5: F1000 Faculty Rev-951. DOI: 10.12688/f1000research.7574.1
7. Chung W.H., Hung S.I. Genetic markers and danger signals in Stevens-Johnson syndrome and toxic epidermal necrolysis. Allergol Int 2010; 59(4): 325-332. DOI: 10.2332/allergo-lint.10-RAI-0261
8. Bastuji-Garin S., Rzany B., Stern R.S., Shear N.H., Nal-di L, Roujeau J.C. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch Dermatol 1993; 129: 92-96.
9. Clinical recommendations. Toxic epidermal necrolysis (Stevens-Johnson syndrome) ICD 10: L51. 1/L51. 2. 2016 (in Russ.) http://www.rodv.ru/
10. Kharchenko G.A., Kimirilova O.G. Lyell’s syndrome in children - clinical features, treatment. Rossiys-kiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 2019; 64(1): 99-102. (in Russ.) DOI: 10.21508/1027-4065-2019-64-1-99-102
11. McPherson T., Exton L., Biswas S., Creamer D., Dziewulski P., Newell L. et al. British Association of Dermatologists’ guidelines for the management of Stevens-Johnson syndrome/tox-ic epidermal necrolysis in children and young people, 2018. Br J Dermatol 2019; 181(1): 37-54. DOI: 10.1111/bjd.17841
12. Metry D.W., Jung P., Levy M.L. Use of intravenous immunoglobulin in children with Stevens-Johnson syndrome and toxic epidermal necrolysis: seven cases and review of literature. Pediatrics 2003; 112(6 Pt.1): 1430-1436.
Review
For citations:
Khakimova R.F., Skorokhodkina O.V., Zaynetdinova G.M., Shamsutdinova G.A., Ryzhova G.R., Khakimova M.R., Volkova D.A. Analysis of clinical experience of children with toxic epidermal necropysis. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics). 2020;65(5):181-186. (In Russ.) https://doi.org/10.21508/1027-4065-2020-65-5-181-186